LGALS4 and cancer: Although the number of studies on the role of galectin-4 in cancer remains relatively low (approximately 60 studies in the last ten years, compared to more than a thousand for galectin-3, for example), we are starting to get a better view of its possible implication in cancer, not only outside the cells but also inside, allowing us to pinpoint its role in cancer progression (24–27).